# India Human Genetics Market > India Human Genetics Market Research Report By Application (Wellness & E-Commerce, Preventive Medicine, Diagnostic & Treatment) andBy Test (NIPT, Carrier Testing, Pharmacogenomic Testing, Karyotype Testing, Thrombophilia Testing, Septin 9 Biomarker Testing, NGS, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 10.8% - **2024:** $ 1,589.45 Million - **2025:** $ 1,761.11 Million - **2035:** $ 4,912.15 Million - **Key Players:** Illumina (US), Thermo Fisher Scientific (US), Roche (CH), Agilent Technologies (US), QIAGEN (DE), Myriad Genetics (US), BGI Genomics (CN), Genomatix (DE), Fulgent Genetics (US) **Report ID:** MRFR/LS/47568-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-human-genetics-market-49318 --- ## Market Summary ## **India Human Genetics Market Overview** As per MRFR analysis, the India Human Genetics Market Size was estimated at $1.15 billion in 2023. The India Human Genetics Market is expected to grow from $1.27 billion in 2024 to $4.12 billion by 2035. The India Human Genetics Market CAGR (growth rate) is expected to be around 11.289% during the forecast period (2025 - 2035). ### **Key India Human Genetics Market Trends Highlighted** Biotechnology breakthroughs and a greater focus on individualized care are driving major changes in the Indian human genetics market at the moment. Understanding and using genetic information for diagnoses and cures is becoming more popular among patients and healthcare professionals as the industry shifts to more individualized treatments. Innovation in this field is being strongly supported by government programs designed to advance genomes and biotechnology research. India's capabilities in human genetics are further enhanced by the creation of genomic research centers and partnerships with foreign institutions. The growing need for genetic testing and customized treatments among Indians presents opportunities to enter this market. People are becoming more aware of hereditary disorders and the advantages of preventive genetic screening, which motivates them to use these services. Additionally, the growing pharmaceutical sector is spending more money on genetic research, which is accelerating the creation of specialized therapies based on genetic profiles. Recent trends show a significant rise in partnerships between academic institutions and biotech firms to take advantage of genomics research. A culture of innovation is being fostered by this dynamic, with an emphasis on creating affordable genetic testing options. Additionally, the market is being revolutionized by the growing use of machine learning and artificial intelligence in genetic analysis, which produces faster and more accurate results. All things considered, the Indian human genetics market is expected to expand thanks to government programs, rising consumer awareness, and new technical developments. ## Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **India Human Genetics Market Drivers** ### **Increasing Prevalence of Genetic Disorders** The rising incidence of genetic disorders in India is a significant driver for the India Human Genetics Market. According to a report from the Ministry of Health and Family Welfare, approximately 1 in 10,000 individuals in India is born with a genetic disorder. This statistic indicates a substantial population that may require genetic testing and therapies. Major organizations such as the Indian Council of Medical Research are actively funding research initiatives and awareness campaigns, leading to increased demand for genetic testing services. Furthermore, as the awareness surrounding genetic disorders grows and screening becomes more accessible, it is likely that a larger segment of the population will seek these services, significantly bolstering the market's growth and future prospects. ### **Advancements in Genetic Research and Technology** Technological advancements in genetic research and development significantly fuel the growth of the India Human Genetics Market. The Government of India's push for Research and Development in biotechnology has led to the establishment of new laboratories and research facilities. For instance, the Department of Biotechnology has undertaken initiatives to support innovative approaches such as next-generation sequencing technology, which has seen an increase in funding allocation of over 25% in recent years. This enhanced capacity for genetic analysis and testing is crucial for effective disease management, and as technology continues to evolve, the market is expected to expand rapidly. ### **Growing Demand for Personalized Medicine** The shift towards personalized medicine in India presents another vital driver for the India Human Genetics Market. According to the National Health Policy of 2017, there is a growing acknowledgment of the need for tailored medical treatments that address individual genetic profiles. This trend toward personalized healthcare is powered by both healthcare providers and patients. For instance, established biotechnology firms in India, such as Biocon and Dr. Reddy's Laboratories, are investing heavily in genomics and individualized treatment regimens. As patients become more informed and seek therapies that consider their unique genetic makeup, the demand for genetic testing and analysis services will rise, propelling the market growth. ## **India Human Genetics Market Segment Insights** ### **Human Genetics Market Application Insights** The Application segment within the India Human Genetics Market has seen notable growth due to increasing awareness of personalized healthcare and advancements in genetic research. The significance of this segment can be largely attributed to its diverse range of applications, particularly in areas like Wellness and E-Commerce, Preventive Medicine, and Diagnostic and Treatment. In the realm of Wellness and E-Commerce, there has been a surge in genetic testing products that cater to health enthusiasts looking for personalized solutions. The rise of digital platforms has facilitated the accessibility of genetic testing services, allowing individuals to gain insights into their health and wellness, thereby promoting preventive measures. On the other hand, Preventive Medicine is becoming increasingly critical, with genetic screenings expected to play a pivotal role in identifying predispositions to various diseases, allowing for early intervention strategies. Governments are investing in preventive healthcare initiatives which not only aim to reduce healthcare costs but also focus on enhancing the population's overall health standards. Moreover, the Diagnostic and Treatment aspect of the Application segment is gaining traction as clinical professionals utilize genetic information to refine treatment plans. This approach has led to improved outcomes for patients suffering from genetically-linked disorders. The emphasis on precision medicine is reshaping the healthcare landscape in India. Furthermore, the push for advanced research in genetic disorders is backed by both public and private sector initiatives, fueling the demand for innovative solutions tailored to the Indian populace. Overall, the various facets of the Application segment are interconnected, each contributing to the broader objectives of enhancing healthcare practices and promoting individual well-being. As the India Human Genetics Market continues to evolve, these applications stand to play an essential role, underlining the growing significance of genetics in contemporary healthcare solutions. ## Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Human Genetics Market Test Insights** The Test segment of the India Human Genetics Market encompasses a wide array of applications that are increasingly crucial in personalized medicine and genetic research. Notably, Non-Invasive Prenatal Testing (NIPT) has gained significant ground due to its safe and accurate assessment of genetic conditions in unborn children, making it a preferred choice for expectant parents. Carrier Testing is also pivotal, as it enables individuals to understand their genetic risks for inheritable conditions, which is essential for family planning in the Indian context. Pharmacogenomic Testing offers insights into how an individual's genetic makeup affects their response to medications, thereby facilitating tailored treatment plans that improve efficacy and reduce adverse effects. Karyotype Testing and Thrombophilia Testing play critical roles in diagnosing chromosomal abnormalities and understanding blood clotting disorders, respectively. Further, Septin 9 Biomarker Testing is significant in detecting colorectal cancer early, enhancing treatment outcomes in a country with rising cancer incidences. Next-Generation Sequencing (NGS) serves as a cutting-edge technology that provides comprehensive genetic information, thus revolutionizing research and diagnostics in multiple areas. With such diverse applications and a growing emphasis on early detection and precision medicine, the Test segment is set to experience substantial growth in India, driven by increasing awareness and the rising prevalence of genetic disorders. ## **India Human Genetics Market Key Players and Competitive Insights** The India Human Genetics Market is witnessing notable growth and transformation, driven by advancements in genetic research and technology, increasing awareness among the population about genetic disorders, and the demand for personalized medicine. The competitive landscape is characterized by a mix of established multinational corporations and emerging local players striving to enhance their market positions through innovation, partnerships, and strategic investments. The proliferation of genetic testing services, coupled with government initiatives promoting healthcare innovations, has further intensified competition among key stakeholders. As a result, companies are innovating their product offerings and forming alliances, aiming to capture a larger share of a rapidly evolving market. Illumina has made a significant mark in the India Human Genetics Market with its innovative next-generation sequencing technologies. Renowned for its strong research focus, Illumina has successfully established a robust market presence in India, targeting hospitals, research institutions, and laboratories. The company is recognized for its pioneering work in genomic studies and personalized medicine, providing high-throughput sequencing platforms and comprehensive genomic solutions tailored for various applications including oncology, reproductive health, and infectious diseases. Illumina’s strength lies in its strong brand reputation, commitment to advancing genomics, extensive distribution network, and established relationships with local research partners, all of which have positioned the company as a leader in the Indian genetic testing landscape. Zydus Cadila operates prominently within the India Human Genetics Market, focusing on biopharmaceuticals and genetic testing services. As a major player, Zydus Cadila has developed key products that cater to several therapeutic areas, including genetic disorders and oncology. The company’s strengths include its extensive research and development capabilities, a strong manufacturing base, and a comprehensive portfolio of genetic tests aimed at improving patient outcomes. Zydus Cadila has also been active in pursuing mergers and acquisitions to bolster its capabilities and expand its offerings in the genomics space. This proactive approach to innovation and growth enhances its competitive edge in the market, allowing Zydus Cadila to maintain a resilient presence in the ever-evolving landscape of human genetics in India. ### Key Companies in the India Human Genetics Market Include: - Illumina - Zydus Cadila - Novartis - Strand Life Sciences - Biocon - Genomic Health - Bristol-Myers Squibb - Avesthagen - Thermo Fisher Scientific - Vinta Biosciences - Roche - Bharat Biotech - **[MedGenome](https://diagnostics.medgenome.com/microsites/genetic-insights-for-better-health/)** - Merck KGaA - Qiagen ### **India Human Genetics Market Developments** The India Human Genetics Market has witnessed significant developments recently. Illumina has been advancing its genetic sequencing technologies, leading to a rise in applications within diagnostics and research. In September 2023, Zydus Cadila announced a partnership with Novartis to enhance genetic therapies and personalized medicine approaches in India. Strand Life Sciences has reported expanding its genomic services, focusing on cancer genetics, which reflects the increasing demand for precision medicine in the country. In October 2023, Biocon's collaboration with Genomic Health aims to develop novel biomarkers, enhancing diagnostics in oncology, while Thermo Fisher Scientific has emphasized growth in genetic testing, bolstered by the rising prevalence of genetic disorders in India. Furthermore, MedGenome recently engaged in discussions to acquire small genomic startups to expand its market footprint. Market valuation is experiencing growth due to innovative products and increasing investments in genetic research, which impact healthcare delivery in India positively. Notable events in the last few years include the rising prevalence of personal genomics services and significant investments in biotechnology infrastructure, contributing to the market's expansion in the nation. As a whole, these advancements underscore the dynamic nature of the human genetics sector in India. ## **India Human Genetics Market Segmentation Insights** ### **Human Genetics Market Application Outlook** - Wellness & E-Commerce - Preventive Medicine - Diagnostic & Treatment ### **Human Genetics Market Test Outlook** - NIPT - Carrier Testing - Pharmacogenomic Testing - Karyotype Testing - Thrombophilia Testing - Septin 9 Biomarker Testing - NGS ## Market Drivers ### Government Initiatives and Funding Government initiatives aimed at promoting genetic research and healthcare are pivotal for the human genetics market. The Indian government has allocated substantial funding for biotechnology and genomics research, which is expected to bolster the development of genetic testing technologies. Programs such as the National Health Mission and the Biotechnology Industry Research Assistance Council (BIRAC) are designed to support innovation in genetic research. These initiatives not only enhance the infrastructure for genetic studies but also encourage public-private partnerships, which may lead to the commercialization of genetic tests. As a result, the human genetics market is likely to benefit from increased investment in research and development, ultimately improving healthcare outcomes and accessibility for the Indian population. ### Rising Prevalence of Genetic Disorders The increasing incidence of genetic disorders in India is a crucial driver for the human genetics market. With an estimated 6-8 million people affected by genetic conditions, the demand for genetic testing and counseling services is on the rise. This trend is further fueled by the growing awareness of hereditary diseases among the population. As healthcare providers and patients seek to understand genetic risks, the human genetics market is likely to expand significantly. The Indian government has also initiated various health programs aimed at early detection and management of genetic disorders, which may enhance the market's growth prospects. Furthermore, advancements in genetic research and technology are expected to provide better diagnostic tools, thereby increasing the accessibility and affordability of genetic testing services across the country. ### Growing Awareness of Preventive Healthcare The rising awareness of preventive healthcare among the Indian population is a significant driver for the human genetics market. As individuals become more health-conscious, there is a growing inclination towards genetic testing for early detection of potential health risks. This trend is reflected in the increasing number of health check-up packages that include genetic tests. Moreover, educational campaigns by healthcare providers and non-governmental organizations are playing a vital role in informing the public about the benefits of genetic testing. The human genetics market is expected to see a surge in demand as more people opt for proactive health management strategies, potentially leading to a more informed and health-oriented society. ### Technological Advancements in Genetic Research Technological advancements in genetic research are transforming the landscape of the human genetics market. Innovations such as next-generation sequencing (NGS) and CRISPR technology are enabling more accurate and efficient genetic testing. These technologies not only enhance the precision of genetic diagnostics but also reduce the time and cost associated with testing. In India, the integration of artificial intelligence in genetic research is also gaining traction, potentially leading to breakthroughs in personalized medicine. As these technologies become more accessible, the human genetics market is likely to experience accelerated growth, with an increasing number of laboratories adopting advanced genetic testing methods to meet the rising demand. ### Increase in Chronic Diseases and Lifestyle Disorders The rise in chronic diseases and lifestyle disorders in India is a notable driver for the human genetics market. Conditions such as diabetes, cardiovascular diseases, and obesity have genetic components that can be identified through genetic testing. As the prevalence of these diseases continues to grow, there is an increasing need for genetic insights to guide prevention and treatment strategies. Healthcare providers are recognizing the importance of genetic factors in managing these conditions, which may lead to a greater emphasis on genetic testing in clinical practice. Consequently, the human genetics market is poised for growth as more individuals seek genetic information to better understand their health risks and tailor their lifestyle choices. ## Future Outlook The [Human Genetics Market](https://www.marketresearchfuture.com/reports/human-genetics-market-714) in India is poised for growth at 10.8% CAGR from 2025 to 2035, driven by advancements in technology, increasing healthcare investments, and rising consumer awareness. **New opportunities:** - Development of personalized genetic testing kits for home use. - Expansion of telehealth services for genetic counseling. - Investment in AI-driven data analytics for genetic research. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic investments. ## Segment Insights ### By Application: Wellness & E-Commerce (Largest) vs. Preventive Medicine (Fastest-Growing) In the India human genetics market, the application segment showcases a diverse distribution of values including Wellness & E-Commerce, Preventive Medicine, and Diagnostic & Treatment. Among these, Wellness & E-Commerce holds the largest share, driven by an increasing consumer focus on health and wellness products. The integration of e-commerce platforms has significantly enhanced accessibility and awareness among consumers, leading to higher adoption rates in this segment. On the other hand, Preventive Medicine is emerging as the fastest-growing segment, fueled by a growing emphasis on preventive healthcare and genetic insights. The surge in health consciousness, coupled with advancements in genetic testing technologies, is propelling this segment forward. The increasing prevalence of lifestyle-related diseases is driving demand for proactive healthcare solutions, thereby contributing to the robust growth of Preventive Medicine in the market. Wellness & E-Commerce (Dominant) vs. Preventive Medicine (Emerging) The Wellness & E-Commerce segment stands out as the dominant force within the India human genetics market, characterized by a shift towards personalized health solutions and greater online engagement. This trend is supported by increased awareness and the convenience of purchasing health-related products online. The segment is marked by innovative products that cater to health-conscious consumers seeking to understand their genetic predispositions. Conversely, Preventive Medicine is perceived as an emerging segment, gaining traction due to its proactive approach to healthcare. As consumers become more vigilant about their health, the demand for genetic testing services for preventive measures is on the rise. Both segments play crucial roles in shaping the future of healthcare in India. ### By Test: NIPT (Largest) vs. NGS (Fastest-Growing) In the India human genetics market, the market share distribution shows that NIPT holds a commanding position, contributing significantly to the overall demand. Other segments such as Pharmacogenomic Testing and Carrier Testing also play vital roles, but NIPT remains the most preferred choice due to its non-invasive nature and high accuracy. Meanwhile, NGS is gaining traction among healthcare providers and patients alike, signifying a growing trend towards advanced genomic technologies. The growth trends in this segment are driven by increasing awareness about genetic disorders and advances in technology. The rising prevalence of hereditary diseases and the need for personalized medicine are key factors spurring growth. NGS is particularly noted for its rapid advancements, making it the fastest-growing segment. As research and development continue to flourish, the potential for further market expansion in these areas remains robust. NIPT (Dominant) vs. NGS (Emerging) NIPT, or Non-Invasive Prenatal Testing, stands out as the dominant segment in the India human genetics market, primarily due to its non-invasive methodology that minimizes risk for both mother and child while providing accurate genetic information. On the other hand, NGS, or Next-Generation Sequencing, is perceived as an emerging technology that leverages high-throughput methods to explore genetic variants and mutations comprehensively. While NIPT remains the go-to option for prenatal genetic assessment, NGS is rapidly establishing its footprint, offering advanced insights into genomic data and customization of treatment. The collaboration of these two segments indicates a shift towards personalized healthcare, enhancing patient outcomes significantly. ## Competitive Benchmarking The human genetics market in India is characterized by a dynamic competitive landscape, driven by advancements in genomic technologies and increasing demand for personalized medicine. Key players such as Illumina (US), Thermo Fisher Scientific (US), and Roche (CH) are at the forefront, leveraging innovation and strategic partnerships to enhance their market presence. Illumina (US) focuses on expanding its sequencing technologies, while Thermo Fisher Scientific (US) emphasizes its comprehensive portfolio of genetic analysis tools. Roche (CH) is strategically positioned through its robust diagnostics division, which integrates genetic testing into clinical workflows, thereby enhancing patient outcomes. Collectively, these strategies foster a competitive environment that prioritizes technological advancement and customer-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they set industry standards and drive innovation. This competitive structure encourages smaller firms to innovate and differentiate their offerings, contributing to a vibrant market ecosystem. In October Illumina (US) announced a partnership with a leading Indian healthcare provider to enhance genomic testing capabilities across the region. This collaboration is expected to facilitate access to advanced sequencing technologies, thereby improving diagnostic accuracy and patient care. The strategic importance of this partnership lies in its potential to expand Illumina's footprint in the Indian market, aligning with the growing trend towards personalized medicine. In September Thermo Fisher Scientific (US) launched a new line of genetic analysis products tailored specifically for the Indian market. This initiative aims to address local healthcare needs and enhance the accessibility of genetic testing. The introduction of these products signifies Thermo Fisher's commitment to regional customization, which is likely to strengthen its competitive position and cater to the unique demands of Indian consumers. In August Roche (CH) expanded its genetic testing services by integrating artificial intelligence (AI) into its diagnostic platforms. This move is anticipated to streamline data analysis and improve the accuracy of genetic interpretations. The integration of AI not only enhances Roche's service offerings but also positions the company as a leader in technological innovation within the market. As of November current trends in the human genetics market include a pronounced shift towards digitalization, sustainability, and AI integration. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve, with a greater emphasis on innovation and technology rather than price-based competition. Companies that prioritize supply chain reliability and technological advancements will likely emerge as leaders in this rapidly evolving market. ## Recent News & Developments The India Human Genetics Market has witnessed significant developments recently. Illumina has been advancing its genetic sequencing technologies, leading to a rise in applications within diagnostics and research. In September 2023, Zydus Cadila announced a partnership with Novartis to enhance genetic therapies and personalized medicine approaches in India. Strand Life Sciences has reported expanding its genomic services, focusing on cancer genetics, which reflects the increasing demand for precision medicine in the country. In October 2023, Biocon's collaboration with Genomic Health aims to develop novel biomarkers, enhancing diagnostics in oncology, while Thermo Fisher Scientific has emphasized growth in genetic testing, bolstered by the rising prevalence of genetic disorders in India. Furthermore, MedGenome recently engaged in discussions to acquire small genomic startups to expand its market footprint. Market valuation is experiencing growth due to innovative products and increasing investments in genetic research, which impact healthcare delivery in India positively. Notable events in the last few years include the rising prevalence of personal genomics services and significant investments in biotechnology infrastructure, contributing to the market's expansion in the nation. As a whole, these advancements underscore the dynamic nature of the human genetics sector in India. ## Report Scope | MARKET SIZE 2024 | 1589.45(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1761.11(USD Million) | | MARKET SIZE 2035 | 4912.15(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.8% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Illumina (US), Thermo Fisher Scientific (US), Roche (CH), Agilent Technologies (US), QIAGEN (DE), Myriad Genetics (US), BGI Genomics (CN), Genomatix (DE), Fulgent Genetics (US) | | Segments Covered | Application, Test | | Key Market Opportunities | Advancements in gene editing technologies create transformative opportunities in the human genetics market. | | Key Market Dynamics | Rising demand for personalized medicine drives innovation and competition in the human genetics market. | | Countries Covered | India | ## Frequently Asked Questions **Q: What is the current valuation of the India human genetics market?** A: The market valuation was $1589.45 Million in 2024. **Q: What is the projected market size for the India human genetics market by 2035?** A: The projected valuation for 2035 is $4912.15 Million. **Q: What is the expected CAGR for the India human genetics market during 2025 - 2035?** A: The expected CAGR during this period is 10.8%. **Q: Which companies are the key players in the India human genetics market?** A: Key players include Illumina, Thermo Fisher Scientific, Roche, Agilent Technologies, QIAGEN, Myriad Genetics, BGI Genomics, Genomatix, and Fulgent Genetics. **Q: What are the main application segments in the India human genetics market?** A: Main application segments include Wellness & E-Commerce, Preventive Medicine, and Diagnostic & Treatment. **Q: What was the market size for the Preventive Medicine segment in 2024?** A: The Preventive Medicine segment was valued at $600 Million in 2024 and is projected to reach $1800 Million. **Q: How does the Diagnostic & Treatment segment perform in terms of market size?** A: The Diagnostic & Treatment segment had a valuation of $789.45 Million in 2024, with a potential growth to $2512.15 Million. **Q: What are the key testing segments in the India human genetics market?** A: Key testing segments include NIPT, Carrier Testing, Pharmacogenomic Testing, Karyotype Testing, Thrombophilia Testing, Septin 9 Biomarker Testing, NGS, and Others. **Q: What was the market size for NGS in 2024?** A: The NGS segment was valued at $500 Million in 2024, with a potential increase to $1500 Million. **Q: What does the future hold for the India human genetics market?** A: The market appears poised for substantial growth, potentially reaching $4912.15 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-human-genetics-market-49318*